Do persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision?
This is the first study to relate ARM risk genotypes with mesopic visual function in clinically normal persons. These preliminary results could become of clinical importance because mesopic vision may be used as a biomarker to document subclinical retinal changes in persons with risk genotypes and to determine whether those persons progress into manifest disease.
Our data suggest that stunning had no influence on ASR and is not a point of clinical consideration with respect to this aspect.